BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 18718623)

  • 1. Direct association of the HPV16 E7 oncoprotein with cyclin A/CDK2 and cyclin E/CDK2 complexes.
    Nguyen CL; Münger K
    Virology; 2008 Oct; 380(1):21-5. PubMed ID: 18718623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct activation of cyclin-dependent kinase 2 by human papillomavirus E7.
    He W; Staples D; Smith C; Fisher C
    J Virol; 2003 Oct; 77(19):10566-74. PubMed ID: 12970441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of c-Myc contributes to bovine papillomavirus type 1 E7-induced cell proliferation.
    Fan X; Liu Y; Chen JJ
    J Biol Chem; 2003 Oct; 278(44):43163-8. PubMed ID: 12937171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-beta-mediated cell cycle arrest of HPV16-immortalized human ectocervical cells correlates with decreased E6/E7 mRNA and increased p53 and p21(WAF-1) expression.
    Rorke EA; Zhang D; Choo CK; Eckert RL; Jacobberger JW
    Exp Cell Res; 2000 Aug; 259(1):149-57. PubMed ID: 10942587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E7 properties of mucosal human papillomavirus types 26, 53 and 66 correlate with their intermediate risk for cervical cancer development.
    Mansour M; Touka M; Hasan U; Bellopede A; Smet A; Accardi R; Gabet AS; Sylla BS; Tommasino M
    Virology; 2007 Oct; 367(1):1-9. PubMed ID: 17568647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the p53-mediated G1 growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoprotein.
    Jones DL; Münger K
    J Virol; 1997 Apr; 71(4):2905-12. PubMed ID: 9060648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anchorage-independent transcription of the cyclin A gene induced by the E7 oncoprotein of human papillomavirus type 16.
    Schulze A; Mannhardt B; Zerfass-Thome K; Zwerschke W; Jansen-Dürr P
    J Virol; 1998 Mar; 72(3):2323-34. PubMed ID: 9499093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus type 16 E7 maintains elevated levels of the cdc25A tyrosine phosphatase during deregulation of cell cycle arrest.
    Nguyen DX; Westbrook TF; McCance DJ
    J Virol; 2002 Jan; 76(2):619-32. PubMed ID: 11752153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E7 abolishes raf-induced arrest via mislocalization of p21(Cip1).
    Westbrook TF; Nguyen DX; Thrash BR; McCance DJ
    Mol Cell Biol; 2002 Oct; 22(20):7041-52. PubMed ID: 12242284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus E7 proteins stimulate proliferation independently of their ability to associate with retinoblastoma protein.
    Caldeira S; de Villiers EM; Tommasino M
    Oncogene; 2000 Feb; 19(6):821-6. PubMed ID: 10698500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus E7 oncoproteins bind a single form of cyclin E in a complex with cdk2 and p107.
    McIntyre MC; Ruesch MN; Laimins LA
    Virology; 1996 Jan; 215(1):73-82. PubMed ID: 8553588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initiation of DNA synthesis by human papillomavirus E7 oncoproteins is resistant to p21-mediated inhibition of cyclin E-cdk2 activity.
    Ruesch MN; Laimins LA
    J Virol; 1997 Jul; 71(7):5570-8. PubMed ID: 9188631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HeLa cells are phenotypically limiting in cyclin E/CDK2 for efficient human papillomavirus DNA replication.
    Lin BY; Ma T; Liu JS; Kuo SR; Jin G; Broker TR; Harper JW; Chow LT
    J Biol Chem; 2000 Mar; 275(9):6167-74. PubMed ID: 10692408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the human papillomavirus type 16 E7 protein with the S-phase-specific E2F-cyclin A complex.
    Arroyo M; Bagchi S; Raychaudhuri P
    Mol Cell Biol; 1993 Oct; 13(10):6537-46. PubMed ID: 8413252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of the binding affinity of different human papillomavirus E7 proteins for the tumour suppressor pRb by a plate-binding assay.
    Dong WL; Caldeira S; Sehr P; Pawlita M; Tommasino M
    J Virol Methods; 2001 Oct; 98(1):91-8. PubMed ID: 11543887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oligomerization properties of the viral oncoproteins adenovirus E1A and human papillomavirus E7 and their complexes with the retinoblastoma protein.
    Clements A; Johnston K; Mazzarelli JM; Ricciardi RP; Marmorstein R
    Biochemistry; 2000 Dec; 39(51):16033-45. PubMed ID: 11123931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of the human E2F transcription factor to the retinoblastoma protein but not to cyclin A is abolished in HPV-16-immortalized cells.
    Pagano M; Dürst M; Joswig S; Draetta G; Jansen-Dürr P
    Oncogene; 1992 Sep; 7(9):1681-6. PubMed ID: 1323816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of both the retinoblastoma tumor suppressor and p21 by the human papillomavirus type 16 E7 oncoprotein is necessary to inhibit cell cycle arrest in human epithelial cells.
    Helt AM; Funk JO; Galloway DA
    J Virol; 2002 Oct; 76(20):10559-68. PubMed ID: 12239337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential patterns of cell cycle regulatory proteins expression in transgenic models of thyroid tumours.
    Coppée F; Depoortere F; Bartek J; Ledent C; Parmentier M; Dumont JE
    Oncogene; 1998 Aug; 17(5):631-41. PubMed ID: 9704929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the binding of the human papillomavirus type 16 and cottontail rabbit papillomavirus E7 proteins to the retinoblastoma gene product.
    Haskell KM; Vuocolo GA; Defeo-Jones D; Jones RE; Ivey-Hoyle M
    J Gen Virol; 1993 Jan; 74 ( Pt 1)():115-9. PubMed ID: 8380832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.